Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
304.99M | 331.53M | 445.58M | 424.55M | 398.63M | 363.85M | Gross Profit |
200.69M | 219.88M | 296.68M | 280.63M | 268.61M | 242.94M | EBIT |
57.24M | 61.64M | 67.11M | 34.94M | 77.36M | 67.79M | EBITDA |
78.35M | 82.57M | 72.43M | 51.15M | 103.40M | 96.05M | Net Income Common Stockholders |
75.45M | 73.49M | 18.50M | -4.41M | 15.50M | 8.81M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
65.72M | 108.50M | 24.11M | 34.93M | 61.04M | 66.18M | Total Assets |
293.85M | 346.29M | 354.88M | 377.79M | 446.97M | 457.00M | Total Debt |
71.11M | 73.94M | 116.81M | 142.95M | 140.90M | 161.95M | Net Debt |
5.38M | -34.56M | 92.70M | 108.03M | 79.86M | 95.77M | Total Liabilities |
189.13M | 198.84M | 236.58M | 263.10M | 273.82M | 281.83M | Stockholders Equity |
80.53M | 122.02M | 85.99M | 79.13M | 127.55M | 127.53M |
Cash Flow | Free Cash Flow | ||||
68.44M | 76.22M | 56.66M | 50.30M | 67.22M | 79.57M | Operating Cash Flow |
74.52M | 83.28M | 72.71M | 57.01M | 75.64M | 87.09M | Investing Cash Flow |
86.41M | 85.42M | -13.67M | -5.78M | -8.69M | 18.31M | Financing Cash Flow |
-120.71M | -84.26M | -69.83M | -77.35M | -72.06M | -71.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | C$1.18B | 15.44 | 71.61% | 3.57% | 9.38% | 117.85% | |
73 Outperform | C$297.41M | 2.36 | 33.87% | 2.31% | -29.54% | 667.77% | |
72 Outperform | C$1.70B | 43.52 | 6.93% | 5.08% | 8.76% | 14.05% | |
61 Neutral | C$176.87M | ― | -4.48% | ― | -0.69% | 8.08% | |
59 Neutral | C$1.02B | 30.45 | -3.53% | ― | 17.19% | -191.01% | |
54 Neutral | $5.38B | 3.31 | -45.11% | 3.29% | 16.82% | 0.04% | |
46 Neutral | C$3.61M | ― | -239.50% | ― | 3.03% | -410.90% |
Medical Facilities Corporation announced the results of its 2025 Annual Meeting of Shareholders, where all five nominees for the board of directors were elected. Additionally, shareholders approved the appointment of Raymond Chabot Grant Thornton LLP as auditors. This outcome ensures continuity in the company’s leadership and financial oversight, potentially strengthening its operational stability and investor confidence.
Medical Facilities Corporation announced a cash dividend of Cdn $0.09 per common share, payable on July 15, 2025, to shareholders of record as of June 30, 2025. This dividend is designated as an ‘eligible dividend’ under Canadian tax law, potentially benefiting shareholders with favorable tax treatment. The announcement reflects the company’s ongoing commitment to providing shareholder value and may enhance its attractiveness to investors seeking income through dividends.
Medical Facilities Corporation reported stable financial results for the first quarter of 2025, with facility service revenue remaining flat at $81.7 million despite one less surgical day. The company saw a 2.2% increase in surgical cases and a slight rise in EBITDA to $17.3 million. A significant highlight was the return of $44.3 million to shareholders through share repurchases, reflecting a strategic focus on capital return. The company’s strong cash position, with $65.7 million in cash and equivalents, supports its ongoing operations and shareholder value initiatives.
Medical Facilities Corporation is set to announce its first quarter 2025 financial results on May 8, 2025, before the market opens. The results will be accessible on SEDAR+ and the company’s website, with an earnings conference call scheduled for the same morning. This announcement is crucial for stakeholders as it provides insights into the company’s financial health and operational performance, potentially impacting its market positioning and investor relations.
Medical Facilities Corporation has announced a cash dividend of Cdn $0.09 per common share, payable on April 15, 2025, to shareholders of record as of March 31, 2025. This announcement reflects the company’s ongoing commitment to providing shareholder value and may influence investor perceptions positively, reinforcing its stable financial health and strategic positioning in the healthcare industry.
Medical Facilities Corporation reported its financial results for the fourth quarter and full year 2024, highlighting a strong year marked by the sale of Black Hills Surgical Hospital, which bolstered its financial position. The company ended the year with a cash position of $108.5 million, repurchased shares worth $16.6 million, and fully repaid its corporate credit facility. Despite a slight decline in surgical case volumes due to an industry-wide shortage of intravenous saline fluids, the company achieved growth in income from operations and adjusted EBITDA. The sale of BHSH significantly enhanced the company’s ability to return capital to shareholders and focus on operational excellence and quality care.